Let me first thank you, Congresswoman Kelly and Congressman Payne, for your leadership. Your leadership is very much appreciated, and your constituents in your respective districts should be very proud of each one of you. I know the…
G. K. Butterfield
The Public Record
G. K. Butterfield is a Democratic politician from North Carolina, born on April 27, 1946. He served as a member of the U.S. House of Representatives, representing North Carolina's 1st congressional district from 2004 until 2022. During his tenure, Butterfield focused on issues such as healthcare, education, and civil rights, advocating for policies that support underserved communities. He has been a prominent voice for African American representation in Congress and has served in various leadership roles within the Democratic Party. Butterfield's career in public service also includes time as a judge and a member of the North Carolina Utilities Commission.
More than one out of every four people in the eastern North Carolina district I represent live in poverty.
It is in everyone's best interest to reduce traffic fatalities and injuries, and it is my belief that eventually this technology can be helpful to that end.
As chairman of the Congressional Black Caucus, I know that many of the conditions which can be treated using cells from cord blood like sickle cell anemia disproportionately impact African Americans.
I just wanted to reach across the aisle and say to my colleagues that the law is working and let us make it work and let us get healthcare to all Americans because they deserve it.
All in all, we need more African American donations and collections, and they will provide better matches to African American patients.
the 6-3 decision that for the second time affirms the Affordable Care Act, which was the historic law that we debated in this committee some years ago, and I was part of that debate, and our committee passed it, it passed the Congress, and…
A bipartisan bill, proposed by Reps. Mike Pompeo (R-Kan.) and G.K. Butterfield (D-N.C.), would block states from requiring GMO labeling.
The Safe and Accurate Food Labeling Act introduced to this Congress by Representatives Mike Pompeo and G.K. Butterfield would ensure that the labeling of biotech ingredients of food products is based on consistent standards using sound…
The demonization of genetically modified foods continues despite objective science proving to the contrary.
Prostate cancer is a national epidemic, the most common cancer in men. One in seven men will be diagnosed, with more than 220,000 new cases each year, and 28,000 men will die from prostate cancer this year. Prostate cancer, Mr. Speaker …
First, let me begin by thanking the gentleman from New Jersey for his leadership and for his willingness to lead this hour, not only tonight, but for agreeing to do it throughout this year. I thank the gentleman so very much for his…
It is critically important that we support the James Zadroga 9/11 Health and Compensation Reauthorization Act.
Recently Congresswoman Capps and myself introduced a bill that would prohibit a rental car that receives a notification about any defect or non-compliance with Federal motor vehicle safety standards to rent or sell the vehicle unless the…
The Congressional Black Caucus will present eight or nine speakers on the Democratic side in just a few minutes. I am the first of many who will be speaking. We come to the floor today to express our deepest sympathy and support to the…
The PRV Program cost taxpayers absolutely nothing--let me repeat: nothing--while at the same time helping to speed treatments and potential cures to pediatric rare disease patients who desperately need them.
I look forward to continuing to work with you and our colleagues to see that 21st Century Cures meets and crosses the finish line.
The Pediatric PRV Program addressed the market failures we have seen as rare pediatric disease drugs have struggled to market by creating financial incentives for rare pediatric disease drug development in the form of vouchers.
I would ask unanimous consent to have two letters inserted into the record, the first one addressed to Members of the House and dated April 28.
the second one, Mr. Chairman, addressed to Mr. Pompeo and me and dated April 16, 2015, is from 29 biotechnology industry stakeholders.





